Constitutive expression of il-12r{beta}2 on human multiple myeloma cells delineates a novel therapeutic target
admin The interleukin-12 (IL-12) organ (R) B2 factor acts as ontogeny cistron in manlike accent and habitual B-cell leukemias/lymphomas and IL-12rb2–deficient mice amend impromptu decentralised plasmacytomas. With this background, we investigated the persona of IL-12Rβ2 in binary myeloma (MM) pathogenesis. Here we exhibit the following: (1) IL-12Rβ2 was spoken in direct MM cells but down-regulated compared with connatural polyclonal plasmablastic cells and ECF cells (PCs). IL-6 dampened IL-12Rβ2 countenance on polyclonal plasmablastic cells and MM cells. (2) IL-12 low the proangiogenic state of direct MM cells in vitro and attenuated significantly (P = .001) the tumorigenicity of the NCI-H929 radiophone distinction in SCID/NOD mice by inhibiting radiophone proliferation and angiogenesis. The latter phenomenon was institute to depend on abolished countenance of a panoramic commission of proangiogenic genes and up-regulated countenance of the antiangiogenic genes IFN-, IFN-, protoplasm factor-4, and TIMP-2. Inhibition of the angiogenic possibleness of direct MM cells was attendant to down-regulated countenance of the proangiogenic genes CCL11, tube endothelial-cadherin, CD13, and AKT and to up-regulation of an IFN-–related antiangiogenic pathway. Thus, IL-12Rβ2 direct restrains MM radiophone growth, and targeting of IL-12 to ontogeny cells holds prospect as newborn therapeutic strategy. (Source: Blood)
Posted in Cancer |